China Grants Approval for Pfizer’s Antiviral Covid Pill
- Paxlovid is first foreign Covid-19 treatment approved by China
- Regulator requires unspecified conditional requirements
This article is for subscribers only.
Sign up for Next China, a weekly email on where the nation stands now and where it's going next.
China granted emergency approval for Pfizer Inc.’s Covid-19 pill in a promising sign the country could open up further to foreign vaccines and treatments for the virus.